ARHGDIB and cancer: However, the data obtained from public databases including all BRCA subtypes and analyzed with the “Kaplan-Meier Plotter” (an online tool available for exploring the correlation between the expression of any gene and survival of patients with cancer (https://kmplot.com (accessed on 25 January 2023)) [90], show that a high RNA expression level of RhoGDI2 is associated with a lower probability of overall survival (Figure 5).